Effects of cysteine on the pharmacokinetics of intravenous 2-(allylthio)pyrazine, a new chemoprotective agent, in rats with protein-calorie malnutrition

International Journal of Pharmaceutics

Volumn 255, Issue 1-2, 2003, Pages 1-11

  Kim, Yoon Gyoon ^a   Cho, Min Kyung ^b   Kwon, Jong Won ^c   Kim, Dong Hyun ^d   Kim, Sang Geon ^b   Lee, Myung Gull ^b  

^a Dankook University   (South Korea)

^b Seoul National University   (South Korea)

^c Dong A Pharmaceutical Company   (South Korea)

^d Korea Institute of Science and Technology   (South Korea)

Author keywords

2 (Allylthio)pyrazine; Pharmacokinetics; Protein calorie malnutrition with or without oral cysteine; Rats

Indexed keywords

2 (ALLYLTHIO)PYRAZINE; CASEIN; CYSTEINE; METHYLTRANSFERASE;

AREA UNDER THE CURVE; BLOOD LEVEL; CHEMOPROPHYLAXIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEEDING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; RAT; RAT STRAIN; REVIEW; STEADY STATE; URINARY EXCRETION;

EID: 0037436951     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(03)00054-1     Document Type: Review

References (36)

1. Bu S.C., Kim Y.G., Kim S.H., Lee M.G. Effects of enzyme inducers and inhibitor on the pharmacokinetics of intravenous 2-(allylthio)pyrazine, a new chemoprotective agent, in rats. Biopharm. Drug Dispos. 21:2000;157-164.
2. Buchanan N. Drug kinetics in protein energy malnutrition. S. Afr. Med. J. 53:1978;327-330.
3. Chiou W.L. Critical evaluation of potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. J. Pharmacokinet. Biopharm. 6:1978;539-546.
4. Chiou W.L. New calculation method of mean apparent drug volume of distribution and application to rational dosage regimen. J. Pharm. Sci. 68:1979;1067-1069.
5. Chiou W.L. New calculation method of mean total body clearance of drugs and its application to dosage regimens. J. Pharm. Sci. 69:1980;90-91.
6. Cho M.K., Kim Y.G., Lee M.G., Kim S.G. Suppression of rat hepatic cytochrome P450s by protein-calorie malnutrition: complete or partial restoration by cysteine or methionine supplementation. Arch. Biochem. Biophys. 372:1999;150-158.
7. Cho M.K., Kim Y.G., Lee M.G., Kim S.G. The effect of cysteine on the altered expression of class alpha and mu glutathione S-transferase genes in the rat liver during protein-calorie malnutrition. Biochem. Biophys. Acta. 1502:2000;235-246.
8. Correia, M.A., 1995. Rat and human liver cytochromes P450. Substrate and inhibitor specificities and functional markers. In: Oritz de Montellano, P.R. (Ed.), Cytochrome P450. Structure, Mechanism, and Biochemistry, 2nd ed. Plenum Press, New York and London, pp. 607-630.
9. Denke, M., Wilson, J.D., 1998. Protein and energy malnutrition. In: Fauci, A.S., Braunwald, E., Isselbacher, K.J., Wilson, J.D., Martin, J.B., Kasper, D.L., Hauser, S.L., Longo, D.L. (Eds.), Principles of Internal Medicine, 14th ed. McGraw-Hill, New York, pp. 452-454.
10. Eatman F.B., Colburn W.A., Boxenbaum H.G., Posmanter H.N., Weinfeld R.E., Ronfeld R., Weissman L., Moore J.D., Gibaldi M., Kaplan S.A. Pharmacokinetics of diazepam following multiple dose oral administration to healthy human subjects. J. Pharmacokinet. Biopharm. 5:1977;481-494.
11. Ericksson M., Catz C., Yaffe S.J. Effect of weanling malnutrition upon hepatic drug metabolism. Biol. Neonate. 27:1975;339-351.
12. Gibaldi, M., Perrier, D., 1982. Pharmacokinetics, 2nd ed. Marcel Dekker, New York.
13. Han K.S., Lee M.G. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects. Drug Metab. Dispos. 27:1999;221-226.
14. Han K.S., Woo S.-J., Koo C.H., Lee M.G. Determination of a chemoprotective agent, 2-(allylthio)pyrazine, in plasma, urine and tissue homogenates by high-performance liquid chromatography. J. Chromatogr. B. 710:1998a;239-242.
15. Han K.S., Woo S.-J., Koo C.H., Lee M.G. Stability, blood partition, and protein binding of a chemoprotective agent, 2-(allylthio)pyrazine. Res. Commun. Mol. Pathol. Pharmacol. 101:1998b;171-178.
16. Jung D. Disposition of acetaminophen in protein-calorie malnutrition. J. Pharmacol. Exp. Ther. 232:1985;178-182.
17. Kawamura A., Yoshida Y., Kimura N., Oda H., Kakinuma A. Phosphorylation/dephosphorylation steps are crucial for induction of CYP2B1 and CYP2B2 gene expression by phenobarbital. Biochem. Biophys. Res. Commun. 264:1999;530-536.
18. Kim, D.-H., 1999. In vitro and in vivo metabolism of 2-(allylthio)pyrazine in rats. In: 2-(Allylthio)pyrazine, A New Chemopreventive Agent. Han Rim Won Publishing Company, Seoul, South Korea, pp. 109-116.
19. Kim S.H., Choi Y.M., Lee M.G. Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition. J. Pharmacokinet. Biopharm. 21:1993;1-17.
20. X-174 DNA strand breakage. Yakhak Hoeji. 40:1996;727-733.
21. Kim N.D., Kwak M.K., Kim S.G. Inhibition of cytochrome P450 2E1 expression by 2-(allylthio)pyrazine, a potential chemoprotective agent: hepatoprotective effects. Biochem. Pharmacol. 53:1997;261-269.
22. Kim S.G., Nam S.Y., Kim C.W., Cho C.K., Kim N.D. Radioprotective effects of 2-(allylthio)pyrazine, an experimental chemopreventive agent: effects on detoxifying enzyme induction. Res. Commun. Mol. Pathol. Pharmacol. 101:1998;275-288.
23. Kim Y.G., Cho M.K., Kwon J.W., Kim S.G., Lee M.G. Effects of cysteine on the pharmacokinetics of intravenous adriamycin in rats with protein-calorie malnutrition. Res. Commun. Mol. Pathol. Pharmacol. 107:2000;361-376.
24. Kim Y.G., Cho M.K., Kwon J.W., Kim S.G., Lee M.G. Effects of cysteine on the pharmacokinetics and pharmacodynamics of intravenous and oral azosemide in rats with protein-calorie malnutrition. Life Sci. 68:2001a;2329-2345.
25. Kim Y.G., Cho M.K., Kwon J.W., Kim S.G., Chung S.J., Shim C.-K., Lee M.G. Effects of cysteine on the pharmacokinetics of intravenous phenytoin in rats with protein-calorie malnutrition. Int. J. Pharm. 229:2001b;45-55.
26. Komori M., Oda Y. A major glucocorticoid-inducible P450 in rat liver is not P450 3A1. J. Biochem. 116:1994;114-120.
27. Krishnaswamy K. Drug metabolism and pharmacokinetics in malnutrition. Clin. Pharmacokinet. 3:1978;216-240.
28. Lee S.H., Lee M.G. Effects of phenobarbital 3-methylcholanthrane or chloramphenicol pretreatment on the pharmacokinetics and pharmacodynamics of azosemide in rats. Biopharm. Drug Dispos. 18:1997;371-386.
29. Lee H.J., Lee M.G. Effects of dexamethasone on the pharmacokinetics of adriamycin after intravenous administration to rats. Res. Commun. Mol. Pathol. Pharmacol. 105:1999;87-96.
30. Otterness D.M., Keith R.A., Kerremans A.L., Weinshilboum R.M. Mouse liver thiol methyltransferase. Assay conditions biochemical properties, and strain variation. Drug Metab. Dispos. 14:1986;680-688.
31. Ramdath D.D., Golden M.H. Elevated glutathione S-transferase activity in erythrocytes from malnourished children. Eur. J. Clin. Nutr. 47:1993;658-665.
32. Spatzenegger M., Horsmans Y., Verbeeck R.K. Differential activities of CYP1A isozymes in hepatic and intestinal microsomes of control and 3-methylcholanthrene-induced rats. Pharmacol. Toxicol. 86:2000;71-77.
33. Surh Y.-J., Park K.K., Kim S.G., Sohn Y., Kim N.D., Liem A., Miller J.A. Chemoprevention of vinyl carbamate- or vinyl carbamate epoxide-induced hepatotoxicity, mutagenicity, and tumorigenicity by 2-(allylthio)pyrazine. Proc. Am. Assoc. Cancer Res. 38:1997;370.
34. 14C ] benzoic acid in protein-energy deficient rats Toxicol. Lett. 5:1980;363-367.
35. Wykes L.J., Fioroto M., Burrin D.G., Rosario M.D., Frazer M.E., Pond W.G., Jahoor F. Chronic low protein intakes reduce tissue protein synthesis in a pig model of protein malnutrition. J. Nutr. 126:1996;1481-1488.
36. Yue T.L., Varma D.R. Pharmacokinetics, metabolism and disposition of salicylate in protein-deficient rats. Drug Metab. Dispos. 10:1982;147-152.